Emilio Besada

Summary

Affiliation: University Hospital of North Norway
Country: Norway

Publications

  1. ncbi request reprint Rapid growing mycobacteria and TNF-α blockers: case report of a fatal lung infection with Mycobacterium abscessus in a patient treated with infliximab, and literature review
    E Besada
    University Hospital North Norway, Rheumatology, Tromsø, Norway
    Clin Exp Rheumatol 29:705-7. 2011
  2. doi request reprint Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre
    Emilio Besada
    Department of Rheumatology, University Hospital of North Norway, Post Box 14, 9038 Tromsø, Norway
    Rheumatology (Oxford) 52:2041-7. 2013
  3. doi request reprint Should Pneumocystis jiroveci prophylaxis be recommended with Rituximab treatment in ANCA-associated vasculitis?
    Emilio Besada
    Institute of Clinical Medicine, University of Tromsø, Bone and Joint Research Group, Tromsø, Norway
    Clin Rheumatol 32:1677-81. 2013
  4. ncbi request reprint Imported case of visceral leishmaniasis presenting as pancytopenia in a Norwegian patient treated with methotrexate and etanercept for psoriasis arthritis
    Emilio Besada
    University North Norway, Tromso, Norway
    Rheumatol Int 33:2687-9. 2013
  5. doi request reprint Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review
    Emilio Besada
    Bone and Joint Research Group, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    Int J Hematol 97:800-3. 2013
  6. doi request reprint Sustained hypogammaglobulinemia under rituximab maintenance therapy could increase the risk for serious infections: a report of two cases
    Emilio Besada
    Revmatologisk avdeling, Nevro og ortopediklinikken, Universitetssykehuset Nord Norge, postboks 14, 9038 Tromsø, Norway
    Rheumatol Int 33:1643-4. 2013
  7. doi request reprint Ultrasonographic resolution of the vessel wall oedema with modest clinical improvement in a large-vessel vasculitis patient treated with tocilizumab
    Emilio Besada
    Department of Rheumatology, University Hospital of North Norway, postboks 14, 9038 Tromsø, Norway
    Clin Rheumatol 31:1263-5. 2012
  8. doi request reprint Characteristics of late onset neutropenia in rheumatologic patients treated with rituximab: a case review analysis from a single center
    E Besada
    Department of Rheumatology, University Hospital North Norway, postboks 14, Tromsø, 9038, Norway
    QJM 105:545-50. 2012
  9. doi request reprint Should rheumatoid factor in rheumatoid arthritis be sent to Davy Jones's Locker?
    E Besada
    Department of Rheumatology, University Hospital of North Norway, Tromsø, Norway
    Scand J Rheumatol 41:85-8. 2012
  10. ncbi request reprint Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis
    Emilio Besada
    University Hospital North Norway, Rheumatology, Tromsø, Norway
    Clin Exp Rheumatol 29:85-8. 2011

Detail Information

Publications11

  1. ncbi request reprint Rapid growing mycobacteria and TNF-α blockers: case report of a fatal lung infection with Mycobacterium abscessus in a patient treated with infliximab, and literature review
    E Besada
    University Hospital North Norway, Rheumatology, Tromsø, Norway
    Clin Exp Rheumatol 29:705-7. 2011
    ..Fortuitum had a resolution of their symptoms with discontinuation of TNF-α blockers and antibiotics...
  2. doi request reprint Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre
    Emilio Besada
    Department of Rheumatology, University Hospital of North Norway, Post Box 14, 9038 Tromsø, Norway
    Rheumatology (Oxford) 52:2041-7. 2013
    ..Our study aims to evaluate the long-term efficacy and safety of chronic pre-emptive RTX therapy in GPA...
  3. doi request reprint Should Pneumocystis jiroveci prophylaxis be recommended with Rituximab treatment in ANCA-associated vasculitis?
    Emilio Besada
    Institute of Clinical Medicine, University of Tromsø, Bone and Joint Research Group, Tromsø, Norway
    Clin Rheumatol 32:1677-81. 2013
    ....
  4. ncbi request reprint Imported case of visceral leishmaniasis presenting as pancytopenia in a Norwegian patient treated with methotrexate and etanercept for psoriasis arthritis
    Emilio Besada
    University North Norway, Tromso, Norway
    Rheumatol Int 33:2687-9. 2013
    ..The patient resided extensively in southern Spain, a zone endemic for leishmania. ..
  5. doi request reprint Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review
    Emilio Besada
    Bone and Joint Research Group, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    Int J Hematol 97:800-3. 2013
    ..This suggests that bortezomib, a proteasome inhibitor that inhibits angiogenesis and production of paraproteins, is a promising treatment in type-1 cryoglobulinemic vasculitis...
  6. doi request reprint Sustained hypogammaglobulinemia under rituximab maintenance therapy could increase the risk for serious infections: a report of two cases
    Emilio Besada
    Revmatologisk avdeling, Nevro og ortopediklinikken, Universitetssykehuset Nord Norge, postboks 14, 9038 Tromsø, Norway
    Rheumatol Int 33:1643-4. 2013
    ..Our patients have features similar to common variable immunodeficiency patients, and therefore prolonged very low levels of immunoglobulins could heighten the risk for severe infections...
  7. doi request reprint Ultrasonographic resolution of the vessel wall oedema with modest clinical improvement in a large-vessel vasculitis patient treated with tocilizumab
    Emilio Besada
    Department of Rheumatology, University Hospital of North Norway, postboks 14, 9038 Tromsø, Norway
    Clin Rheumatol 31:1263-5. 2012
    ..But the clinical improvement in our patient has been moderate and short-lived due to persistent Th1 cells activity...
  8. doi request reprint Characteristics of late onset neutropenia in rheumatologic patients treated with rituximab: a case review analysis from a single center
    E Besada
    Department of Rheumatology, University Hospital North Norway, postboks 14, Tromsø, 9038, Norway
    QJM 105:545-50. 2012
    ..Late onset neutropenia (LON) secondary to rituximab has been reported as an adverse event in the treatment of hematological malignancies but reports on autoimmune diseases are scarce...
  9. doi request reprint Should rheumatoid factor in rheumatoid arthritis be sent to Davy Jones's Locker?
    E Besada
    Department of Rheumatology, University Hospital of North Norway, Tromsø, Norway
    Scand J Rheumatol 41:85-8. 2012
    ..This has led to a 70% reduction in RF assays performed annually...
  10. ncbi request reprint Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis
    Emilio Besada
    University Hospital North Norway, Rheumatology, Tromsø, Norway
    Clin Exp Rheumatol 29:85-8. 2011
    ..To compare the diagnostic efficiency of anti-MCV, anti-CCP2 and RF detection for patients with RA...
  11. doi request reprint Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler's syndrome: a case report and literature review
    Emilio Besada
    Rheumatology, University Hospital North Norway, Tromsø, Norway
    Clin Rheumatol 29:567-71. 2010
    ..The current case history and the literature review already suggest an important role for IL-1 as a mediator in the pathophysiology of Schnitzler's syndrome...